Shareholders' Equity

3 Months Ended

Mar. 31, 2022

Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]

Shareholders' Equity

Shareholders' Equity

Stock Repurchase Program

The 2021 Repurchase Program authorizes the repurchase of up to 850,000 shares, or approximately 5%, of the Corporation’s outstanding common stock. This authority may be exercised from time to time and in such amounts as market conditions warrant, and subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions, and other corporate liquidity requirements and priorities. The 2021 Repurchase Program expires on December 31, 2022 and may be modified, suspended, or discontinued at any time. As of March 31, 2022, no shares have been repurchased under the 2021 Repurchase Program.

Regulatory Capital Requirements

Capital levels at March 31, 2022 exceeded the regulatory minimum levels to be considered “well capitalized.”

The following table presents the Corporation’s and the Bank’s actual capital amounts and ratios, as well as the corresponding minimum and well capitalized regulatory amounts and ratios that were in effect during the respective periods:

(Dollars in thousands)	Actual			For Capital Adequacy Purposes			To Be “Well Capitalized” Under Prompt Corrective Action Provisions
	Amount	Ratio		Amount	Ratio		Amount	Ratio
March 31, 2022
Total Capital (to Risk-Weighted Assets):
Corporation	$586,872	14.15	%	$331,834	8.00	%	N/A	N/A
Bank	574,138	13.85		331,722	8.00		$414,652	10.00	%
Tier 1 Capital (to Risk-Weighted Assets):
Corporation	552,481	13.32		248,875	6.00		N/A	N/A
Bank	539,747	13.02		248,791	6.00		331,722	8.00
Common Equity Tier 1 Capital (to Risk-Weighted Assets):
Corporation	530,482	12.79		186,656	4.50		N/A	N/A
Bank	539,747	13.02		186,593	4.50		269,524	6.50
Tier 1 Capital (to Average Assets): (1)
Corporation	552,481	9.46		233,500	4.00		N/A	N/A
Bank	539,747	9.25		233,387	4.00		291,734	5.00
December 31, 2021
Total Capital (to Risk-Weighted Assets):
Corporation	578,137	14.01		330,105	8.00		N/A	N/A
Bank	565,087	13.70		330,025	8.00		412,532	10.00
Tier 1 Capital (to Risk-Weighted Assets):
Corporation	546,362	13.24		247,578	6.00		N/A	N/A
Bank	533,312	12.93		247,519	6.00		330,025	8.00
Common Equity Tier 1 Capital (to Risk-Weighted Assets):
Corporation	524,363	12.71		185,684	4.50		N/A	N/A
Bank	533,312	12.93		185,639	4.50		268,146	6.50
Tier 1 Capital (to Average Assets): (1)
Corporation	546,362	9.36		233,534	4.00		N/A	N/A
Bank	533,312	9.14		233,434	4.00		291,793	5.00

(1)    Leverage ratio.

In addition to the minimum regulatory capital required for capital adequacy purposes outlined in the table above, the Corporation is required to maintain a minimum capital conservation buffer, in the form of common equity, of 2.50% in order to avoid restrictions on capital distributions and discretionary bonuses. The Corporation’s capital levels exceeded the minimum regulatory capital requirements plus the capital conservation buffer at March 31, 2022 and December 31, 2021.

The Bancorp owns the common stock of two capital trusts, which have issued trust preferred securities. In accordance with GAAP, the capital trusts are treated as unconsolidated subsidiaries. At both March 31, 2022 and December 31, 2021, $22.0 million in trust preferred securities were included in the Tier 1 capital of the Corporation for regulatory capital reporting purposes pursuant to the capital adequacy guidelines of the Board of Governors of the Federal Reserve System.

In accordance with regulatory capital rules, the Corporation elected the option to delay the estimated impact of ASC 326 on its regulatory capital over a two-year deferral and subsequent three-year transition period ending December 31, 2024. As a result, capital ratios exclude the full impact of the increased ACL on loans and unfunded loan commitments attributed to the adoption of ASC 326, adjusted for an approximation of the after-tax provision for credit losses attributable to ASC 326

relative to the incurred loss methodology during the two-year deferral period. The cumulative difference at the end of the deferral period is being phased-in to regulatory capital over the three-year transition period, which began January 1, 2022.